Michael A. Dyer, MD
Assistant Professor
Boston University School of Medicine
Dept of Radiation Oncology

MD, Harvard Medical School




Michael A. Dyer, MD is an Assistant Professor of Radiation Oncology at the Boston University School of Medicine and its affiliate Boston Medical Center. He received his AB in Comparative Literature from Brown University (2005) and his MD from Harvard Medical School (2012). He completed an internship in Internal Medicine at Beth Israel Deaconess Medical Center (2013), and a residency in Radiation Oncology at the Harvard Radiation Oncology Program (2017), with training at Massachusetts General Hospital, Dana-Farber/Brigham and Women’s Cancer Center, Beth Israel Deaconess Medical Center, Boston Children's Hospital, and Boston Medical Center. Dr. Dyer is board certified in Radiation Oncology by the American Board of Radiology. His clinical specialties include treatment of genitourinary, gynecologic, cutaneous, central nervous system, and head and neck malignancies, as well as the use of intensity-modulated radiation therapy, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) (including Cyberknife®), and brachytherapy. His research interests include decision analysis, patient-reported outcomes and quality of life research, and clinical trials.

VA Boston Healthcare System



2009-2012 Harvard University Committee on General Scholarships: Harold A. Berry Scholarship (for academic achievement)
2008-2009 Albert Schweitzer Community Service Fellow



RTOG STUDY 3507
01/04/2019 - 01/04/2022 (PI)
Radiation Therapy Oncology Group


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Moeller AR, Clancy PE, Qureshi MM, Guill JR, Dyer MA, Hirsch AE, Truong MT, Mak KS. Placard in Hand: A Simple, Inexpensive Intervention to Improve On-Treatment Visit Compliance in a Safety Net Radiation Oncology Patient Population. JCO Oncol Pract. 2020 Sep 16; OP2000343.View Related Profiles. PMID: 32936711
     
  2. Nguyen R, Patel AG, Griffiths LM, Dapper J, Stewart EA, Houston J, Johnson M, Akers WJ, Furman WL, Dyer MA. Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma. Cancer Immunol Immunother. 2020 Sep 11. PMID: 32915319
     
  3. Kim KN, Dyer MA, Qureshi MM, Shah NK, Grillone GA, Faden DL, Jalisi SM, Truong MT. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer. Am J Otolaryngol. 2020 Sep - Oct; 41(5):102544.View Related Profiles. PMID: 32505989
     
  4. Shah NK, Qureshi MM, Dyer MA, Truong MT, Mak KS. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. J Gastrointest Cancer. 2020 Mar 09.View Related Profiles. PMID: 32152823
     
  5. Clay MR, Pinto EM, Cline C, Tran QT, Lin T, Dyer MA, Shi L, Wu H, Pounds SB, Zambetti GP, Orr BA, Ribeiro RC. DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry. JCO Precis Oncol. 2019; 3. PMID: 32923859
     
  6. Patel SA, Qureshi MM, Dyer MA, Jalisi S, Grillone G, Truong MT. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer. Cancer. 2019 Oct 01; 125(19):3367-3377.View Related Profiles. PMID: 31206637
     
  7. Yan SX, Qureshi MM, Dyer M, Truong MT, Mak KS. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer. Lung Cancer. 2019 05; 131:147-153.View Related Profiles. PMID: 31027693
     
  8. Shah NK, Qureshi MM, Dyer MA, Patel SA, Kim K, Everett PC, Grillone GA, Jalisi SM, Truong MT. Optimal sequencing of chemoradiotherapy for locally advanced laryngeal cancer. Laryngoscope. 2019 10; 129(10):2313-2320.View Related Profiles. PMID: 30628077
     
  9. Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):10-19. PMID: 29757775
     
  10. Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Lung Cancer. 2018 10; 124:135-142.View Related Profiles. PMID: 30268452
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 11 distinct years, with a maximum of 4 publications in 2019 and 2020

YearPublications
20072
20081
20101
20121
20131
20141
20151
20161
20182
20194
20204


Mentorship for students, residents, or fellows interested in oncology, clinical research, outcomes research, and decision analysis. Also mentorship for LGBT students and trainees.

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Diversity Mentor
  • Project Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

830 Harrison Avenue
Boston MA 02118
Google Map


Dyer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department